Meer inligting ― Afrikaans

Urticaria kom gewoonlik voor met intense jeukende, verhoogde kolle. Dit gaan soms gepaard met swelling van die onderliggende weefsels. Behandeling behels hoofsaaklik die vermyding van snellers, indien bekend. Eerste‑lyn medikasie sluit nuwe antihistamiene in, wat aangepas kan word na hoër dosisse indien nodig. Ander medikasie soos ouer antihistamiene, H2‑blokkers, leukotrien‑reseptorantagoniste, sterker antihistamiene en kortkursusbehandelings met kortikosteroïede kan bygevoeg word as ekstra ondersteuning. In gevalle waar urtikaria voortduur ten spyte van hierdie maatreëls, kan pasiënte na spesialiste verwys word vir bykomende terapieë soos omalizumab of cyclosporine.
Urticaria commonly presents with intensely itchy raised welts. It is sometimes accompanied by swelling of the underlying tissues. Treatment primarily involves avoiding triggers, if known. First-line medication includes newer antihistamines, which can be adjusted to higher doses if needed. Other medications like older antihistamines, H2 blockers, leukotriene receptor antagonists, stronger antihistamines, and short courses of corticosteroids can be added as extra support. In cases where urticaria persists despite these measures, patients might be referred to specialists for additional therapies such as omalizumab or cyclosporine.

Hierdie oorsig gee 'n uiteensetting van die nuutste riglyne vir die behandeling van urtikaria en bied nuwe insig in die oorsake daarvan.
This review outlines the latest guidelines for treating urticaria and offers new understandings of its causes.

Second-generation H1-antihistamines (e.g., cetirizine, loratadine, fexofenadine), Omalizumab, Ciclosporin, and short courses only of systemic corticosteroids